Company Growth (employees)
Merrimack Pharmaceuticals was founded in 2000 and is headquartered in Cambridge, US
Key People at Merrimack Pharmaceuticals
Richard Peters
President and Chief Executive Officer
Merrimack Pharmaceuticals Office Locations
Merrimack Pharmaceuticals has an office in Cambridge
Cambridge, US (HQ)
1 Kendall Square
Merrimack Pharmaceuticals Data and Metrics
Merrimack Pharmaceuticals Financial Metrics
Merrimack Pharmaceuticals's revenue was reported to be $144.3 m in FY, 2016
USD
Net income (Q1, 2017) | (30.2 m) |
Market capitalization (19-Sep-2017) | 192.3 m |
Cash (31-Mar-2017) | 17.2 m |
Merrimack Pharmaceuticals's current market capitalization is $192.3 m.
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 47.8 m | 102.8 m | 89.3 m | 144.3 m |
Revenue growth, % | 115% | (13%) | 62% | |
Cost of goods sold | 6.9 m | |||
Gross profit | 137.4 m |
| USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 21.3 m | 33.7 m | 28.1 m | ||||||
Cost of goods sold | 1.9 m | 1 m | |||||||
Gross profit | 31.8 m | 27.1 m | |||||||
Gross profit Margin, % | 94% | 96% |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 65.1 m | 35.7 m | 185.6 m | 21.5 m |
Accounts Receivable | 5.9 m | 3.3 m | 6.5 m | 17.5 m |
Inventories | 5.5 m | 4.7 m | 5.5 m | 14.6 m |
Current Assets | 166.6 m | 132.1 m | 201.4 m | 57.4 m |
| USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|---|---|---|
Cash | 77.8 m | 100.3 m | 28.8 m | 33.7 m | 56.4 m | 48.2 m | 21.5 m | 36.5 m | 17.2 m |
Accounts Receivable | 6.6 m | 2.6 m | 4.2 m | 1.8 m | 2.1 m | 15.6 m | 19.3 m | 22.2 m | 43 k |
Inventories | 8.1 m | 12.3 m | 14.8 m | ||||||
Current Assets | 103.8 m | 162.1 m | 99.3 m | 74.9 m | 70.9 m | 160.7 m | 119 m | 89.6 m | 46.3 m |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | (130.7 m) | (83.6 m) | (147.8 m) | (153.5 m) |
Depreciation and Amortization | 2.6 m | 3.2 m | 4.3 m | 6.2 m |
Accounts Receivable | 3.4 m | 2.6 m | (3.2 m) | (11 m) |
Inventories | 4 m | 827 k | (850 k) | (9.7 m) |
| USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | (18.3 m) | (28 m) | (34.4 m) | (22.9 m) | (42.4 m) | (38.7 m) | (51 m) | (30.3 m) | (30.2 m) |
Accounts Receivable | 6.6 m | 2.6 m | 4.2 m | 1.8 m | 2.1 m | 15.6 m | 19.3 m | 22.2 m | 43 k |
Inventories | 8.1 m | 12.3 m | 14.8 m |
Merrimack Pharmaceuticals Market Value History
Merrimack Pharmaceuticals Median Salaries
Source: 20 public H-1B filings from Merrimack Pharmaceuticals
Market Position of Merrimack Pharmaceuticals
Traffic Overview of Merrimack Pharmaceuticals
Merrimack Pharmaceuticals Online and Social Media Presence
Merrimack Pharmaceuticals News and Updates
January 09, 2017
US Stocks Modestly Lower in Early Trading; Oil Prices Slide
U.S. stock indexes edged mostly lower in early trading Monday, led by declines in energy companies. Oil and gas companies fell the most as the price of crude oil headed lower. Materials stocks notched the biggest gain. Investors had their eye on the latest company earnings and deal news.
October 12, 2016
Boston Vs. NYC Vs. LA Exits: New York Wins On Quantity, LA On Big Winners
Outside of Silicon Valley, New York has seen the most venture-backed companies exit since 2012, over Boston and Los Angeles. In fact, nearly half, 44%, of all the exits in the three cities over the last five years were for … Continued
October 03, 2016
Wall St. Is Down as Health Stocks Slide
Shares of Merrimack Pharmaceuticals fell after the company said it would cut almost a quarter of its work force and would look for a new chief executive.